195 related articles for article (PubMed ID: 17493731)
1. Successful treatment of refractory hypochondriasis with duloxetine.
Politi P; Emanuele E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1145-6. PubMed ID: 17493731
[No Abstract] [Full Text] [Related]
2. [Duloxetin effective in depression and pain: high remission rates obtained].
MMW Fortschr Med; 2006 Jun; 148(23):63. PubMed ID: 16826744
[No Abstract] [Full Text] [Related]
3. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report.
Hazen E; Fava M
J Psychopharmacol; 2006 Sep; 20(5):723-4. PubMed ID: 16401659
[TBL] [Abstract][Full Text] [Related]
4. [FDA approval for the antidepressive drug Cymbalta].
Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
[No Abstract] [Full Text] [Related]
5. [Physical recovery is part of remission].
Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
[No Abstract] [Full Text] [Related]
6. Burning paresthesia related to duloxetine therapy.
Woo YS; Bahk WM
J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
[No Abstract] [Full Text] [Related]
7. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
8. Digging for data on harms in duloxetine trials.
Doshi P; Zito J; dosReis S
BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
[No Abstract] [Full Text] [Related]
9. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
10. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.
Bech P; Kajdasz DK; Porsdal V
Psychopharmacology (Berl); 2006 Oct; 188(3):273-80. PubMed ID: 16960699
[TBL] [Abstract][Full Text] [Related]
12. [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
MMW Fortschr Med; 2006 Jun; 148(23):62. PubMed ID: 16826743
[No Abstract] [Full Text] [Related]
13. Duloxetine: a new selective and dual-acting antidepressant.
Bauer M; Möller HJ; Schneider E
Expert Opin Pharmacother; 2006 Mar; 7(4):421-7. PubMed ID: 16503814
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine in the treatment of social anxiety disorder.
Crippa JA; Filho AS; Freitas MC; Zuardi AW
J Clin Psychopharmacol; 2007 Jun; 27(3):310. PubMed ID: 17502786
[No Abstract] [Full Text] [Related]
15. Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial.
Mico' U; Bruno A; Pandolfo G; Maria Romeo V; Mallamace D; D'Arrigo C; Spina E; Zoccali RA; Muscatello MR
Int Clin Psychopharmacol; 2011 Nov; 26(6):303-10. PubMed ID: 21934625
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine for premenstrual dysphoric disorder: a pilot study.
Mazza M; Harnic D; Catalano V; Janiri L; Bria P
Expert Opin Pharmacother; 2008 Mar; 9(4):517-21. PubMed ID: 18312154
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and safety of duloxetine.
Wise TN
CNS Spectr; 2005 Dec; 10(12 Suppl 19):10-1. PubMed ID: 18841598
[No Abstract] [Full Text] [Related]
18. [Psycho- and pharmacotherapy of depressions. So you combine correctly].
Arnheim K
MMW Fortschr Med; 2009 May; 151(19):20. PubMed ID: 19827439
[No Abstract] [Full Text] [Related]
19. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
20. Effects of duloxetine on painful physical symptoms associated with depression.
Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
